Physician profile
Anthony J Cornetta
NPI 1356348486
$6,315.69
in general payments reported to CMS, 2019-2025
16 companies · $1,348 in 2025
The $1,348 reported for 2025 was more than what 85% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $904 · 2020: $1,059 · 2021: $1,097 · 2022: $372 · 2023: $433 · 2024: $1,103 · 2025: $1,348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,785 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,785.21 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,161.63 | 2019-2025 | Xpress Loprofile, Clarifix, Scopis Ent |
| Neurent Medical Limited | $1,732.08 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Regeneron Healthcare Solutions, INC. | $464.36 | 2023-2025 | Dupixent |
| Intersect Ent, INC. | $389.44 | 2019-2021 | |
| Depuy Synthes Sales INC. | $124.46 | 2020 | |
| Medtronic, INC. | $91.60 | 2022 | |
| Acclarent, INC | $70.49 | 2019 | |
| Genzyme Corporation | $56.31 | 2024-2025 | |
| Spirair, INC. | $38.93 | 2025 | |
| Hikma Pharmaceuticals USA | $37.52 | 2024-2025 | Ryaltris |
| Integra Lifesciences Corporation | $36.33 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Leo Pharma INC. | $28.78 | 2023 | Adbry |
| Averitas Pharma INC. | $27.64 | 2025 | Qutenza |
| Bayer Healthcare Pharmaceuticals INC. | $22.70 | 2025 | |
| Phadia US INC. | $18.46 | 2024 | Immunocap |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.96 | 2025 | Capvaxive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Cornetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.